These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33218402)

  • 21. Cytoreductive surgery followed by HIPEC repetition for secondary ovarian cancer recurrence.
    Cianci S; Ronsini C; Vizzielli G; Tropea A; Biondi A; Scambia G; Fagotti A
    Updates Surg; 2019 Jun; 71(2):389-394. PubMed ID: 30406932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
    Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
    Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
    Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
    Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
    Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
    Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of post-operative platelet-to-white blood cell ratio after splenectomy in patients with advanced ovarian cancer.
    Lathouras K; Panagakis G; Bowden SJ; Saliaris K; Saso S; Haidopoulos D; Fotopoulou C
    Int J Gynecol Cancer; 2019 Oct; 29(8):1292-1297. PubMed ID: 31481452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
    Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW
    J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splenectomy as a part of cytoreductive surgery in ovarian cancer: systematic review and meta-analysis.
    Wang Y; Chen Y; Qin Z; Chen M; Zheng A; Han L
    Int J Gynecol Cancer; 2024 Jul; 34(7):1070-1076. PubMed ID: 38839080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer.
    McCann CK; Growdon WB; Munro EG; Del Carmen MG; Boruta DM; Schorge JO; Goodman A
    Ann Surg Oncol; 2011 Oct; 18(10):2912-8. PubMed ID: 21424880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
    Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
    Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center.
    Filippova OT; Chi DS; Long Roche K; Sonoda Y; Zivanovic O; Gardner GJ; Tew WP; O'Cearbhaill R; Sarraf S; Sun SW; Alexander K; Korc-Grodzicki B; Shahrokni A
    Gynecol Oncol; 2019 Jul; 154(1):77-82. PubMed ID: 31078241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
    Shi T; Zhu J; Feng Y; Tu D; Zhang Y; Zhang P; Jia H; Huang X; Cai Y; Yin S; Jiang R; Tian W; Gao W; Liu J; Yang H; Cheng X; Zang R
    Lancet Oncol; 2021 Apr; 22(4):439-449. PubMed ID: 33705695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PROFAST: A randomised trial implementing enhanced recovery after surgery for highcomplexity advanced ovarian cancer surgery.
    Sánchez-Iglesias JL; Carbonell-Socias M; Pérez-Benavente MA; Monreal Clua S; Manrique-Muñoz S; García Gorriz M; Burgos-Peláez R; Segurola Gurrutxaga H; Pamies Serrano M; Pilar Gutiérrez-Barceló MD; Serrano-Castro S; Balcells-Farré MT; Pérez-Barragán C; Scaillet-Houberechts A; Cossio-Gil Y; Gil-Moreno A
    Eur J Cancer; 2020 Sep; 136():149-158. PubMed ID: 32688208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survival.
    Ross MS; Burriss ME; Winger DG; Edwards RP; Courtney-Brooks M; Boisen MM
    Gynecol Oncol; 2018 Aug; 150(2):306-310. PubMed ID: 29929924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative Complications After Distal Pancreatectomy Performed During Cytoreductive Surgery for Gynecologic Malignancies.
    Mahdi H; Rose PG; Gonzalez S; DeBernardo R; Knight J; Michener C; Moselmi-Kebria M
    Int J Gynecol Cancer; 2015 Jul; 25(6):1128-33. PubMed ID: 25962116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Splenectomy as a part of debulking surgery in patients with advanced ovarian cancer].
    Derlatka P; Grabowska-Derlatka L; Sieńko J; Dańska-Bidzińska A
    Ginekol Pol; 2014 Aug; 85(8):605-8. PubMed ID: 25219141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery.
    Chen W; Ye S; Wu Y; Pei X; Xiang L; Ping B; Shan B; Yang H
    J Ovarian Res; 2021 Aug; 14(1):113. PubMed ID: 34461965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
    Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
    Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenectomy in epithelial ovarian cancer surgery.
    El Hajj H; Ferraioli D; Meus P; Beurrier F; Tredan O; Ray-Coquard I; Chopin N
    Int J Gynecol Cancer; 2023 Jun; 33(6):944-950. PubMed ID: 36948526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes for 14 consecutive patients with solid pseudopapillary neoplasms who underwent laparoscopic distal pancreatectomy.
    Nakamura Y; Matsushita A; Katsuno A; Yamahatsu K; Sumiyoshi H; Mizuguchi Y; Uchida E
    Asian J Endosc Surg; 2016 Feb; 9(1):32-6. PubMed ID: 26567867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.